Skip to content

Envoy Medical COCH Deferred Tax Liabilities

Deferred Tax Liabilities at other companies

HES
Hess MidstreamHESM
$500K0.0%
Main Street Capital logo
Main Street CapitalMAIN
$112.92M+24.1%
Warrior Met Coal logo
Warrior Met CoalHCC
$856K+2.9%
CorMedix logo
CorMedixCRMD
$144.89M
MYR Group logo
MYR GroupMYRG
$49.91M-5.0%
SOL
SOLSSOLS
$237M

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesOther.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's deferred tax liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's deferred tax liabilities?
Envoy Medical (COCH) reported deferred tax liabilities of -$276K in Q4 2025.
What is the long-term trend for Envoy Medical's deferred tax liabilities?
Over 2 years (2023 to 2025), Envoy Medical's deferred tax liabilities has grown at a 271.5% compound annual growth rate (CAGR), from $20K to -$276K.
What does deferred tax liabilities mean?
Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.